Poor outcomes for RCC with nodal involvement: Time to reconsider staging criteria?October 12, 2018Renal Cell Carcinoma
Primary, metastatic ccRCC share mutational featuresOctober 12, 2018Renal Cell CarcinomaGenitourinary Cancer
Updated analysis from JAVELIN Renal 101 to be presented at ESMO 2018October 11, 2018Renal Cell CarcinomaGenitourinary Cancer
Epacadostat plus pembrolizumab shows promise in advanced solid tumorsOctober 5, 2018Immuno-oncologyMelanomaRenal Cell CarcinomaLung CancerHead & Neck/Thyroid CancersGynecologic Cancer
Better therapy, not earlier diagnosis, explains improved RCC survivalOctober 2, 2018Renal Cell CarcinomaGenitourinary Cancer
Pazopanib is active against renal, other neoplasms of von Hippel-Lindau diseaseOctober 2, 2018Renal Cell CarcinomaGenitourinary Cancer
For solitary renal tumors, RFA looks good at 10 yearsOctober 1, 2018Renal Cell CarcinomaGenitourinary Cancer
SBRT controls oligometastatic RCC in majority of patientsSeptember 17, 2018Renal Cell CarcinomaGenitourinary Cancer
TKIs feasible and effective in Brazilian population with clear cell RCCSeptember 14, 2018Renal Cell CarcinomaGenitourinary Cancer
Osteonecrosis of jaw in mRCC higher with denosumab/antiangiogenicsSeptember 14, 2018Renal Cell CarcinomaGenitourinary CancerPatient & Survivor Care
Prognostic model has clinical utility in mCRPCSeptember 12, 2018Genitourinary CancerRenal Cell Carcinoma
PD1 mRNA may predict response to anti-PD1 monotherapy across cancer typesSeptember 4, 2018Immuno-oncologyMelanomaLung CancerRenal Cell Carcinoma
